Masatake Kurita
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Need for medication to complement catecholamines in smoking cessation of hardcore smokers.
Journal: Neuropsychiatric disease and treatment
Published: October 28, 2017
Entrainment of the Circadian Clock in Neural Stem Cells by Epidermal Growth Factor is Closely Associated with ERK1/2-mediated Induction of Multiple Clock-related Genes.
Journal: Neuroscience
Published: October 10, 2017
Non-24-hour sleep-wake syndrome improved by low-dose valproic acid: a case report.
Journal: Neuropsychiatric disease and treatment
Published: December 23, 2016
Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode.
Journal: Neuropsychiatric disease and treatment
Published: October 06, 2016
Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function.
Journal: Neuropsychiatric disease and treatment
Published: April 05, 2016
The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports.
Journal: Neuropsychiatric disease and treatment
Published: February 25, 2015
The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic study.
Journal: PloS one
Published: November 27, 2013
Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
Journal: Journal of clinical psychopharmacology
Published: August 17, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026